Selected article for: "mixed model and time treatment"
Author: Groeneveld, Geert H; van der Reyden, Tanny J; Joosten, Simone A; Bootsma, Hester J; Cobbaert, Christa M; de Vries, Jutte J C; Kuijper, Ed J; van Dissel, Jaap T
Title: Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial
  • Document date: 2019_5_18
    • ID: 19ueli6e_31
    Snippet: To model the effect of LTA release, and the levels and effects of biomarkers over time in the different treatment groups, we used a linear mixed model (LMM). We used results from the first 48 h of sampling since this is the time window of interest......
    Document: To model the effect of LTA release, and the levels and effects of biomarkers over time in the different treatment groups, we used a linear mixed model (LMM). We used results from the first 48 h of sampling since this is the time window of interest.

    Search related documents:
    Co phrase search for related documents
    • biomarker effect and LMM linear mixed model: 1
    • biomarker effect and mixed model: 1
    • different treatment group and linear mixed model: 1
    • different treatment group and mixed model: 1
    • different treatment group and treatment group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • interest time window and time window: 1
    • linear mixed model and LMM linear mixed model: 1, 2, 3, 4
    • linear mixed model and mixed model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • linear mixed model and time window: 1, 2
    • linear mixed model and treatment group: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • LMM linear mixed model and mixed model: 1, 2, 3, 4
    • lta release and treatment group: 1
    • mixed model and time window: 1, 2, 3
    • mixed model and treatment group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21